Diagnosis & Disease Information

That Nebulous Concept Called Standard of Care

During a session at the 2019 Genitourinary Cancers Symposium (GUCS) held recently in San Francisco, researchers presented findings from phase 3 studies showing that immunotherapy-based combination regimens are superior to sunitinib alone at improving progression-free survival among patients with previously untreated advanced kidney cancer. One study demonstrated improved overall survival. The study presenters concluded that…

Yellow tablets in a man's hand

Unique Drug Cuts CRPC Mets Risk

SAN FRANCISCO—Darolutamide, a structurally unique androgen receptor antagonist, prolongs metastasis-free survival (MFS) and decreases the risk of pain progression in men with nonmetastatic castration-resistant prostate cancer (nmCRPC), without adversely affecting quality of life, according to study findings presented at the 2019 Genitourinary Cancers Symposium and published concurrently in The New England Journal of Medicine. “This…


Better Communication Cuts Down on Surgery-Related Deaths

South Carolina hospitals use a checklist to increase safety in the operating room. As part of a novel program, 14 hospitals in South Carolina reduced post-surgery mortality rates by 22% through the simple act of using a checklist in their operating rooms. The hospitals, which account for almost 40% of the state’s inpatient surgeries, completed…

Next post in Hemodialysis